PL1945272T3 - Sposób prowadzenia scyntygraffi - Google Patents
Sposób prowadzenia scyntygraffiInfo
- Publication number
- PL1945272T3 PL1945272T3 PL06819185T PL06819185T PL1945272T3 PL 1945272 T3 PL1945272 T3 PL 1945272T3 PL 06819185 T PL06819185 T PL 06819185T PL 06819185 T PL06819185 T PL 06819185T PL 1945272 T3 PL1945272 T3 PL 1945272T3
- Authority
- PL
- Poland
- Prior art keywords
- scintigraphy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0522302A GB0522302D0 (en) | 2005-11-01 | 2005-11-01 | Organic compound |
US74678406P | 2006-05-09 | 2006-05-09 | |
EP06819185.7A EP1945272B1 (en) | 2005-11-01 | 2006-10-30 | Method of scintigraphy |
PCT/EP2006/067916 WO2007051773A1 (en) | 2005-11-01 | 2006-10-30 | Method of scintigraphy |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1945272T3 true PL1945272T3 (pl) | 2014-03-31 |
Family
ID=37714608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06819185T PL1945272T3 (pl) | 2005-11-01 | 2006-10-30 | Sposób prowadzenia scyntygraffi |
Country Status (5)
Country | Link |
---|---|
US (1) | US7947673B2 (pl) |
EP (1) | EP1945272B1 (pl) |
JP (1) | JP5322651B2 (pl) |
PL (1) | PL1945272T3 (pl) |
WO (1) | WO2007051773A1 (pl) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8829198B2 (en) * | 2007-10-31 | 2014-09-09 | Proteotech Inc | Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies |
WO2009111611A2 (en) | 2008-03-05 | 2009-09-11 | Proteotech Inc. | Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes |
EP2416788A4 (en) * | 2009-04-07 | 2012-08-22 | Lawrence Bernstein | IDENTIFICATION AND TREATMENT OF CANCER |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5618838A (en) * | 1993-06-18 | 1997-04-08 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Gallium complexes for the treatment of free radical-induced diseases |
MY129541A (en) * | 1996-06-25 | 2007-04-30 | Novartis Ag | Substituded 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
US6558650B1 (en) * | 1998-04-08 | 2003-05-06 | Oregon Health And Science University | Enhancement of cellular gallium uptake |
US6602989B1 (en) * | 2000-05-17 | 2003-08-05 | The Research Foundation Of State University Of New York | Synthesis, characterization, and application of pyridylazo bioconjugates as diagnostic and therapeutic agents |
GB0126618D0 (en) * | 2001-11-06 | 2002-01-02 | Novartis Ag | Organic compounds |
GB0408078D0 (en) | 2004-04-08 | 2004-05-12 | Novartis Ag | Organic compounds |
-
2006
- 2006-10-30 WO PCT/EP2006/067916 patent/WO2007051773A1/en active Application Filing
- 2006-10-30 US US12/091,970 patent/US7947673B2/en not_active Expired - Fee Related
- 2006-10-30 EP EP06819185.7A patent/EP1945272B1/en not_active Not-in-force
- 2006-10-30 JP JP2008538348A patent/JP5322651B2/ja not_active Expired - Fee Related
- 2006-10-30 PL PL06819185T patent/PL1945272T3/pl unknown
Also Published As
Publication number | Publication date |
---|---|
EP1945272B1 (en) | 2013-09-11 |
WO2007051773A1 (en) | 2007-05-10 |
US7947673B2 (en) | 2011-05-24 |
EP1945272A1 (en) | 2008-07-23 |
US20080279962A1 (en) | 2008-11-13 |
JP2009513688A (ja) | 2009-04-02 |
JP5322651B2 (ja) | 2013-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200805297B (en) | Method of using ß-hydroxy-ß-methylbutyrate | |
GB0823478D0 (en) | Method of cementing | |
IL207493A0 (en) | Method of securing pipe elements together | |
EP1864785A4 (en) | SETEROLITHOGRAPHIEVERFAHREN | |
GB0504774D0 (en) | Method | |
GB0503836D0 (en) | Method | |
GB0519303D0 (en) | Chemo-immunotherapy method | |
IL185757A0 (en) | Methods of decreasing calcifcation | |
GB0504096D0 (en) | Method | |
GB0509433D0 (en) | Method | |
GB0504184D0 (en) | Method | |
GB0507123D0 (en) | Method | |
GB0510536D0 (en) | Method | |
GB0508420D0 (en) | Method | |
GB0505756D0 (en) | Method | |
GB0502046D0 (en) | Method | |
EP1964538A4 (en) | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL SUBSTANCES | |
GB0509305D0 (en) | Method | |
GB0509437D0 (en) | Method | |
GB0520981D0 (en) | Method | |
PL1945272T3 (pl) | Sposób prowadzenia scyntygraffi | |
GB0504182D0 (en) | Method | |
GB0509956D0 (en) | Method | |
GB0506670D0 (en) | Method | |
GB0502360D0 (en) | Method |